Definitive Contract 75N93021C00031
Award Date 7/15/21
Potential Completion Date 1/18/25
Potential Value $1.5M
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Monrovia, CA 91016, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
2
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $299,993 Small Business Innovation Research (SBIR) Phase I contract to Chromologic LLC, a minority-owned and Asian-Indian American-owned limited liability company, for the development of "Mobile Health Point-of-Care Diagnostics for Malaria." This contract is focused on research and development of rapid diagnostic technologies for malaria, a...
- This federal contract award, valued at $299,914.00, was granted to Chromologic LLC, a minority-owned, for-profit limited liability company, by the National Institute of Allergy and Infectious Diseases, a civilian agency. The contract, which is a Definitive Contract with a Firm Fixed Price pricing type, is for the SBIR 134 - CHROMOLOGIC project. The contract does not have a set-aside designation and has an ultimate completion date of September 24, 2025. Chromologic is a manufacturer of goods that...
- The National Institute of Allergy and Infectious Diseases (NIAID) has awarded a $299,937 firm fixed-price contract to Chromologic LLC, a minority-owned, for-profit limited liability company, for a Phase I Small Business Innovation Research (SBIR) project titled "CHROMOLOGIC." The contract supports research and development efforts for a "CRIPR-BASED ASSAY FOR PORTABLE TROPICAL INFECTION DIAGNOSIS (CAPTIN-D)." There is no set-aside designation for this contract. Chromologic has...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services. The contract, valued at $224,997.00, was awarded to Chromologic LLC, a minority-owned, for-profit limited liability company, to conduct research and development for the BICER program. The contract has a Firm Fixed Price pricing type and a completion date of September 9, 2016....
- This is a U.S. government contract awarded to Chromologic LLC, a minority-owned, for-profit limited liability company, for a Small Business Innovation Research (SBIR) Phase I project. The contract, valued at $167,497.00, is a firm fixed-price purchase order set aside for small businesses. The contract supports research and development activities in areas such as medical devices, pharmaceuticals, diagnostics, and countermeasures, leveraging Chromologic's expertise in biomedical engineering,...
- This award is for a $1,074,903.98 Firm Fixed Price contract under the Defense Health Agency's (DHA) Small Business Innovation Research (SBIR) program. The contract was awarded to Chromologic LLC, a minority-owned small business, for the development of a Phase II project titled "In-Line, Non-Invasive, Non-Destructive Cell Monitoring in Dynamically Growing Cultures". The project was solicited under DHA SBIR Topic DHA18-006, and the work is to be performed in Monrovia, California....
- This firm fixed-price purchase order was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Chromologic LLC, a minority-owned, for-profit limited liability company, to develop a novel handheld counterfeit drug identifier. The $149,995.80 contract has a completion date of February 28, 2020 and does not utilize any set-aside designation. Chromologic has previously received prime and subcontract awards from federal agencies including the Departments...
- This federal contract award was issued by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to Chromologic LLC, doing business as Chromologic, a minority-owned small business. The $299,980.00 Firm Fixed Price contract is for the development of a "Highly-Efficient Isolation and Fidelity Differentiation of Exosomes (HIFIDE) from Bodily Fluids Kit" under the Small Business Innovation Research (SBIR) program. Chromologic has...
- Chromologic LLC was awarded a firm fixed price, definitive contract valued at $149,949.58 by the Department of the Army Medical Command to conduct research under Phase I of the Small Business Innovation Research program. The contract has a total small business set aside designation and calls for Chromologic to perform work related to proposal number H171-002-0113 at its place of performance in Monrovia, California through April 2018. As a minority-owned, small business, Chromologic will leverage...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Department of the Army Medical Command to Chromologic LLC, a minority-owned small business based in Monrovia, California. The contract has a firm fixed price of $149,823.91 and a completion date of April 24, 2018. As an SBIR Phase I award, this contract funds early-stage research and development efforts, likely focused on developing innovative medical technology solutions. Chromologic has a history of SBIR/STTR...
Chromologic LLC, a minority-owned small business, has been awarded a definitive fixed-price contract valued at $1,498,121 by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases. The contract is for the delivery of mobile health point-of-care diagnostics for malaria, to be performed in Monrovia, California, with work expected to be completed by January 2025. No set-aside designation was used for this award. Through this contract, Chromologic will provide research, development and manufacturing services in support of the agency's efforts to develop rapid diagnostic tests for infectious diseases like malaria.
Generated 3/6/24, 10:18 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00005 | Other Administrative Action | $0 | 3/5/24 | |
| P00004 | Other Administrative Action | $0 | 11/24/21 | |
| P00003 | Funding Only Action | $0 | 11/24/21 | |
| P00002 | Other Administrative Action | $0 | 10/14/21 | |
| P00001 | Funding Only Action | $0 | 9/16/21 |